Since PSMA is expressed in the neovasculature of different solid epithelial cancers and represents a possible target for radioligand-based or antiangiogenic therapeutic strategies, we aimed at investigating PSMA expression in soft tissue and bone tumors as well as in the tumor-associated neovasculature. The gene discussed is FOLH1; the disease is neoplasm.